Gastroenteropancreatic neuroendocrine tumors (NETs) are observed increasingly often [1].
The prevalence in the US of gastrointestinal well differentiated NETs (gastrointestinal …

Multiple endocrine neoplasia type 1 (MEN1) is a rare syndrome characterized by the co-
occurrence of primary hyperparathyroidism, duodenopancreatic neuroendocrine tumours …

Mixed neuroendocrine-non-neuroendocrine neoplasms (MiNEN) are a heterogeneous
subgroup of rare neoplasms that represent about a third of all poorly differentiated …

Background Somatostatin analogues are commonly used to treat symptoms associated with
hormone hypersecretion in neuroendocrine tumors; however, data on their antitumor effects …

Purpose No established treatment exists for pancreatic neuroendocrine tumor (NET)
progression after failure of chemotherapy. Everolimus (RAD001), an oral inhibitor of …

Gastrinomas are neuroendocrine neoplasms, usually located in the duodenum or pancreas,
that secrete gastrin and cause a clinical syndrome known as Zollinger-Ellison syndrome …

Background and aims: Early endoscopic recurrence is frequent after intestinal resection for
Crohn's disease. Bacteria are involved, and probiotics may modulate immune responses to …

Background & Aims: The aim of this study was to evaluate the usefulness of short-term
infliximab combined with azathioprine (AZA) or 6-mercaptopurine (6-MP) in steroid …

Objective We developed a validated index for assessing histological disease activity in UC
and established its responsiveness. Methods Two hundred biopsies were scored. The …

In the CLARINET study, lanreotide Autogel (depot in USA) significantly prolonged
progression-free survival (PFS) in patients with metastatic pancreatic/intestinal …